Impact of Adaptive Radiation Therapy on Toxicity in Prostate Cancer: A Scoping Review

Existing literature reviews have not focused on the acute and late toxicities of non–magnetic resonance imaging (MRI)-guided adaptive radiation therapy (ART), nor on the comparative impacts of non-MRI-guided versus MRI-guided ART, or on the effectiveness of adaptive conventional fractionated radiation therapy (CFRT) and stereotactic body radiation therapy (SBRT) in relation to toxicity in prostate cancer (PCa). The purpose of this scoping review was to systematically identify original articles and evaluate the impact of ART on toxicity in PCa in a comprehensive manner.